Myriad Genetics | MYGN - Capitaux Propres Et Réserves





Capitaux Propres Et Réserves Changement Date
Agilent USD 6.91B 167M 2025-12
Becton, Dickinson and Co. USD 25.28B 108M 2025-12
Bio-Rad Laboratories USD 7.45B 716.8M 2025-12
Bruker USD 2.49B 625.6M 2025-09
Danaher USD 52.53B 1.46B 2025-12
Exact Sciences USD 2.4B 100.37M 2025-12
Hologic USD 5.25B 197.2M 2025-12
Illumina USD 2.72B 342M 2025-12
J&J USD 78.47B 0 2025-09
Mettler Toledo International USD -23.64M 225.56M 2025-12
Myriad Genetics USD 368M 4.8M 2025-12
OraSure Technologies USD 340.83M 21.15M 2025-12
Pacific Biosciences Of California USD 5.35M 30.74M 2025-12
Quest Diagnostics USD 7.17B 88M 2025-12
Quidel USD 1.92B 115.9M 2025-12
Repligen USD 2.11B 1.66B 2025-12
Revvity USD 7.38B 180.27M 2025-09
Standard Biotools USD 424.29M 24.63M 2025-12
Thermo Fisher Scientific USD 53.54B 2.38B 2025-12
Veracyte USD 1.26B 36.61M 2025-09
Waters USD 2.56B 230.55M 2025-12